XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statement of Stockholders' Deficiency - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Balance $ (2,940,871) $ 2,395,213
Issuance of stock for board and consulting fees 9,454 183,628
Comprehensive Income 2 1
Net loss for period (394,061) (729,287)
Balance (3,325,476) (2,940,871)
Common Stock [Member]    
Balance $ 3,263 $ 3,092
Balance, shares 32,630,506 30,921,701
Issuance of stock for board and consulting fees $ 10 $ 171
Issuance of stock for board and consulting fees, shares 101,663 1,708,805
Balance $ 3,273 $ 3,263
Balance, shares 32,732,169 32,630,506
Preferred Stock [Member] | Series C Preferred Stock [Member]    
Balance $ 0 $ 0
Balance, shares 1 1
Issuance of stock for board and consulting fees
Balance $ 0 $ 0
Balance, shares 1 1
Preferred Stock [Member] | Series D Preferred Stock [Member]    
Balance $ 27 $ 27
Balance, shares 270,306 270,306
Issuance of stock for board and consulting fees
Balance $ 27 $ 27
Balance, shares 270,306 270,306
Treasury Stock, Common [Member]    
Balance $ (1,033) $ 1,033
Balance, shares (103,334) (103,334)
Issuance of stock for board and consulting fees
Balance $ 1,033 $ (1,033)
Balance, shares (103,334) (103,334)
Additional Paid-in Capital [Member]    
Balance $ 29,355,626 $ 29,172,169
Issuance of stock for board and consulting fees 9,444 183,457
Balance 29,365,070 29,355,626
Retained Earnings [Member]    
Balance (32,426,429) 31,697,142
Net loss for period (394,061) (729,287)
Balance 32,820,490 (32,426,429)
AOCI Attributable to Parent [Member]    
Balance 127,675 127,674
Comprehensive Income 2 1
Balance $ 127,677 $ 127,675